Lifeward Funding: How Much Did They Raise & Key Investors

How Much Did Lifeward Raise?
Funding & Key Investors

Lifeward, the entity formerly recognized as ReWalk Robotics, has successfully secured a significant capital infusion, bringing its total funding to $31.2M. This latest financial milestone, characterized by a $11.2M strategic investment, underscores the market's confidence in the company's expanded mission to redefine physical rehabilitation and assistive technology. By consolidating its position through these successive financing rounds, Lifeward is effectively scaling its operational capacity to meet the growing global demand for advanced mobility solutions.

The recent capital injection serves as a critical catalyst for the firm, enabling it to accelerate the integration of its diverse portfolio, which now spans from exoskeleton systems to anti-gravity rehabilitation tools. As the company transitions into this new phase of growth, the influx of resources provides the necessary liquidity to sustain its research and development pipeline while solidifying its footprint in the competitive medical device landscape.

What is Lifeward?

Lifeward

Manufacturing

Medical Devices & Equipment

Lifeward operates at the intersection of robotics and clinical rehabilitation, positioning itself as a global leader in life-changing assistive technologies. The company's strategic evolution from a specialized exoskeleton manufacturer to a comprehensive provider of physical therapy solutions is evidenced by its acquisition and integration of technologies such as the ReStore Exo-Suit, MYOLYN FES bikes, and the AlterG Anti-Gravity systems. By focusing on the development of hardware that addresses complex physical limitations, Lifeward is actively setting new benchmarks for the standard of care in neuro-rehabilitation and mobility support. Its market position is defined by a commitment to relentless innovation, aiming to empower individuals with disabilities through high-precision, technology-driven interventions that facilitate greater independence and improved quality of life.

How much funding has Lifeward raised?

Lifeward has raised a total of $31.2M across 2 funding rounds:

2026

Private Equity

$20M

Unspecified

$11.2M

Private Equity (2026): $20M, investors not publicly disclosed

Unspecified (2026): $11.2M, investors not publicly disclosed

Key Investors in Lifeward

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Lifeward?

With the recent capital deployment, Lifeward is poised to execute a multi-faceted growth strategy centered on market penetration and technological synergy. The company is expected to leverage this financing to optimize its supply chain and expand the clinical reach of its AlterG and ReWalk product lines. Furthermore, the strategic focus will likely shift toward enhancing the software-driven capabilities of its existing hardware, ensuring that its portfolio remains at the forefront of the digital health revolution. As Lifeward continues to scale, the primary objective remains the elevation of clinical outcomes, ensuring that its suite of assistive devices becomes an indispensable component of modern physical therapy protocols worldwide.

See full Lifeward company page

See More Financial Insights